CellVoyant

Automata and CellVoyant Announce Strategic Partnership to Deliver AI-Powered Closed-Loop Cell Culture Workflows

13 January 2026 -- California, US -- Automata, a leading provider of modular, fully-integrated and AI-ready lab automation, and CellVoyant, a pioneer in AI foundation models for ‘live’ label-free cell analytics and predictive cell biology, today announced a strategic partnership to deliver AI-powered, adaptive, iterative automation for advanced cell culture and cell-based therapeutic development workflows....

CellVoyant secures £7.6m seed funding to accelerate the development of stem cell therapies with AI

Investment will make stem cell-based therapies more efficient, scalable, and cost-effective 16 January 2024 - Bristol, UK – CellVoyant, an AI-first biotechnology spin-out from the University of Bristol, UK, accelerating the development of novel cell therapies, has announced a £7.6m seed round. Led by Octopus Ventures, with participation from Horizons Ventures, Verve Ventures, and Air...

CellVoyant secures £7.6m seed funding to accelerate the development of stem cell therapies with AI

Investment will make stem cell-based therapies more efficient, scalable and cost-effective 16 January 2024 -- Bristol, UK -- CellVoyant, an AI-first biotechnology spin-out from the University of Bristol, UK, accelerating the development of novel cell therapies, has announced a £7.6m seed round. Led by Octopus Ventures, with participation from Horizons Ventures, Verve Ventures and Air...
Origin Workspace 40 Berkeley Square, Bristol BS8 1HP